SLC26A4

Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.


Solute carrier family 26, member 4
Identifiers
Symbols SLC26A4 ; DFNB4; PDS
External IDs Template:OMIM5 Template:MGI HomoloGene20132
RNA expression pattern
File:PBB GE SLC26A4 206529 x at tn.png
More reference expression data
Orthologs
Template:GNF Ortholog box
Species Human Mouse
Entrez n/a n/a
Ensembl n/a n/a
UniProt n/a n/a
RefSeq (mRNA) n/a n/a
RefSeq (protein) n/a n/a
Location (UCSC) n/a n/a
PubMed search n/a n/a

Solute carrier family 26, member 4, also known as SLC26A4, is a human gene.[1]

Mutations in this gene are associated with Pendred syndrome, the most common form of syndromic deafness, an autosomal-recessive disease. It is highly homologous to the SLC26A3 gene; they have similar genomic structures and this gene is located 3' of the SLC26A3 gene. The encoded protein has homology to sulfate transporters.[1]

References

  1. 1.0 1.1 "Entrez Gene: SLC26A4 solute carrier family 26, member 4".

Further reading

  • Markovich D (2001). "Physiological roles and regulation of mammalian sulfate transporters". Physiol. Rev. 81 (4): 1499–533. PMID 11581495.
  • Baldwin CT, Weiss S, Farrer LA; et al. (1996). "Linkage of congenital, recessive deafness (DFNB4) to chromosome 7q31 and evidence for genetic heterogeneity in the Middle Eastern Druze population". Hum. Mol. Genet. 4 (9): 1637–42. PMID 8541853.
  • Coyle B, Coffey R, Armour JA; et al. (1996). "Pendred syndrome (goitre and sensorineural hearing loss) maps to chromosome 7 in the region containing the nonsyndromic deafness gene DFNB4". Nat. Genet. 12 (4): 421–3. doi:10.1038/ng0496-421. PMID 8630497.
  • Sheffield VC, Kraiem Z, Beck JC; et al. (1996). "Pendred syndrome maps to chromosome 7q21-34 and is caused by an intrinsic defect in thyroid iodine organification". Nat. Genet. 12 (4): 424–6. doi:10.1038/ng0496-424. PMID 8630498.
  • Gausden E, Armour JA, Coyle B; et al. (1996). "Thyroid peroxidase: evidence for disease gene exclusion in Pendred's syndrome". Clin. Endocrinol. (Oxf). 44 (4): 441–6. PMID 8706311.
  • Coucke P, Van Camp G, Demirhan O; et al. (1997). "The gene for Pendred syndrome is located between D7S501 and D7S692 in a 1.7-cM region on chromosome 7q". Genomics. 40 (1): 48–54. doi:10.1006/geno.1996.4541. PMID 9070918.
  • Everett LA, Glaser B, Beck JC; et al. (1997). "Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS)". Nat. Genet. 17 (4): 411–22. doi:10.1038/ng1297-411. PMID 9398842.
  • Li XC, Everett LA, Lalwani AK; et al. (1998). "A mutation in PDS causes non-syndromic recessive deafness". Nat. Genet. 18 (3): 215–7. doi:10.1038/ng0398-215. PMID 9500541.
  • Van Hauwe P, Everett LA, Coucke P; et al. (1999). "Two frequent missense mutations in Pendred syndrome". Hum. Mol. Genet. 7 (7): 1099–104. PMID 9618166.
  • Coyle B, Reardon W, Herbrick JA; et al. (1999). "Molecular analysis of the PDS gene in Pendred syndrome". Hum. Mol. Genet. 7 (7): 1105–12. PMID 9618167.
  • Usami S, Abe S, Weston MD; et al. (1999). "Non-syndromic hearing loss associated with enlarged vestibular aqueduct is caused by PDS mutations". Hum. Genet. 104 (2): 188–92. PMID 10190331.
  • Scott DA, Wang R, Kreman TM; et al. (1999). "The Pendred syndrome gene encodes a chloride-iodide transport protein". Nat. Genet. 21 (4): 440–3. doi:10.1038/7783. PMID 10192399.
  • Masmoudi S, Charfedine I, Hmani M; et al. (2000). "Pendred syndrome: phenotypic variability in two families carrying the same PDS missense mutation". Am. J. Med. Genet. 90 (1): 38–44. PMID 10602116.
  • Reardon W, OMahoney CF, Trembath R; et al. (2000). "Enlarged vestibular aqueduct: a radiological marker of pendred syndrome, and mutation of the PDS gene". QJM : monthly journal of the Association of Physicians. 93 (2): 99–104. PMID 10700480.
  • Bogazzi F, Raggi F, Ultimieri F; et al. (2000). "A novel mutation in the pendrin gene associated with Pendred's syndrome". Clin. Endocrinol. (Oxf). 52 (3): 279–85. PMID 10718825.
  • Bidart JM, Mian C, Lazar V; et al. (2000). "Expression of pendrin and the Pendred syndrome (PDS) gene in human thyroid tissues". J. Clin. Endocrinol. Metab. 85 (5): 2028–33. PMID 10843192.
  • Adato A, Raskin L, Petit C, Bonne-Tamir B (2000). "Deafness heterogeneity in a Druze isolate from the Middle East: novel OTOF and PDS mutations, low prevalence of GJB2 35delG mutation and indication for a new DFNB locus". Eur. J. Hum. Genet. 8 (6): 437–42. doi:10.1038/sj.ejhg.5200489. PMID 10878664.
  • Lohi H, Kujala M, Kerkelä E; et al. (2001). "Mapping of five new putative anion transporter genes in human and characterization of SLC26A6, a candidate gene for pancreatic anion exchanger". Genomics. 70 (1): 102–12. doi:10.1006/geno.2000.6355. PMID 11087667.
  • Royaux IE, Wall SM, Karniski LP; et al. (2001). "Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion". Proc. Natl. Acad. Sci. U.S.A. 98 (7): 4221–6. doi:10.1073/pnas.071516798. PMID 11274445.
  • Campbell C, Cucci RA, Prasad S; et al. (2001). "Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype-phenotype correlations". Hum. Mutat. 17 (5): 403–11. doi:10.1002/humu.1116. PMID 11317356.

Template:WikiDoc Sources